Brind.

Td Securities and TD Cowen provided new analyst ratings and price targets for Tilray Brands.

1 report, 1 independent Updated Aug 7

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Tilray

Keep exploring

The entities involved

Tilray
pharmaceutical and cannabis company
- Both InterCure and Tilray are small-cap healthcare providers.Sun 20:47
- Potential agreement for Carlsberg beer products in the U.S.Wed 19:47

Related events

MarketBeat aggregated consensus rating data for Tilray, which is the subject of a target price reduction and rating change involving Td Securities and TD Cowen.Sep 10
Tilray seeks scale comparable to market leaders in the industry, such as Coca-Cola.Sep 13

Coverage

Newest first; wire copies grouped

Aug 7themarketsdaily.com